RxDoctor Payments Data

Kimberly Riegel

Family · Middle Island, NYNPI 1851417786

Payments from drug & device makers

$3,068in general payments, 2019–2025

Across 140 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$777
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$495
  • Nestle Healthcare Nutrition Inc.$485
  • Johnson & Johnson$214
  • Redhill Biopharma Inc.$162
  • Bristol Myers Squibb$159
  • plus $774 from 11 others

What the payments were for

  • Food & beverage$3,01898%
  • Education$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,068 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OcalivaObeticholic Acid11$101,810
LinzessLinaclotide56$64,009
CreonLipase/Protease/Amylase31$57,825
XifaxanRifaximin19$42,348
Mesalamine16$6,992
SutabSod Sulf/Pot Chloride/Mag Sulf43$6,784
Lubiprostone20$4,835
Famotidine82$2,576
CholestyramineCholestyramine (With Sugar)14$2,311
Dicyclomine Hcl75$1,635
Pantoprazole Sodium110$1,228
Sucralfate30$1,006
Omeprazole140$905
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine16$503
Hydrocortisone28$293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$777$121,83587 claims
Intercept Pharmaceuticals, Inc.Ocaliva$65$101,81011 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$495$42,34819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.

Other family in Middle Island

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →